Get involved

Claim

Opening the claim…

In an analysis not planned in advance, two coders read without counts the 60 main-set trials whose records mention a crossover, unblinding, an open-label period, an extension or a booster; both coded 7 as not following vaccine and placebo groups equally, 6 of them as following the vaccine groups longer, and they differed on 6 more. In those 6 (60,603 participants) the registry's tables give more participants with a serious adverse event in the vaccine groups (584 against 371; risk ratio 1.47, 95% CI 1.29 to 1.68) and more deaths (66 against 25; 2.63, 1.66 to 4.16), almost all from one trial, which has 61 against 23 deaths in the registry (84 of the 91) and 16 against 15 in its published blinded period. Without the 7 trials both coders coded as not equal (61,220 participants), the risk ratios in the rest are 0.97 (0.95 to 1.00) for any serious adverse event and 0.95 (0.90 to 0.99) for death, and for mRNA vaccines against inert placebo 0.98 (0.91 to 1.06) and 0.94 (0.81 to 1.10); without all 13 that either coder coded as not equal (85,490 participants) they are 0.97 (0.95 to 1.00), 0.94 (0.90 to 0.99), 0.97 (0.90 to 1.05) and 0.94 (0.81 to 1.10). · sciencejournal.ai